Literature DB >> 6379684

Liposomes as drug carriers in cancer chemotherapy.

J N Weinstein, L D Leserman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6379684     DOI: 10.1016/0163-7258(84)90035-4

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  15 in total

Review 1.  Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery.

Authors:  Lauren Willis; Don Hayes; Heidi M Mansour
Journal:  Lung       Date:  2012-01-25       Impact factor: 2.584

2.  Improvement of amphotericin B activity during experimental cryptococcosis by incorporation into specific immunoliposomes.

Authors:  F Dromer; J Barbet; J Bolard; J Charreire; P Yeni
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  Selective killing of T lymphocytes by phototoxic liposomes.

Authors:  S Yemul; C Berger; A Estabrook; S Suarez; R Edelson; H Bayley
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

4.  In vitro evaluation of nebulization properties, antimicrobial activity, and regional airway surface liquid concentration of liposomal polymyxin B sulfate.

Authors:  Tejas R Desai; Gregory J Tyrrell; Tina Ng; Warren H Finlay
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

5.  Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice.

Authors:  N Chiannilkulchai; N Ammoury; B Caillou; J P Devissaguet; P Couvreur
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

6.  Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution.

Authors:  P A Steerenberg; G Storm; G de Groot; A Claessen; J J Bergers; M A Franken; Q G van Hoesel; K L Wubs; W H de Jong
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

7.  Preclinical toxicity and pharmacology of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II).

Authors:  R Perez-Soler; J Lautersztain; L C Stephens; K Wright; A R Khokhar
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

8.  Interaction of liposome-associated all-trans-retinoic acid with squamous carcinoma cells.

Authors:  R Parthasarathy; P G Sacks; D Harris; H Brock; K Mehta
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  Organ distribution and tumor uptake of liposome entrapped cis-bis-neodecanoato trans-R, R-1,2 diaminocyclohexane platinum (II) administered intravenously and into the proper hepatic artery.

Authors:  A R Khokhar; K Wright; Z H Siddik; R Perez-Soler
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

10.  Tumor uptake of 67Ga-carrying liposomes.

Authors:  I Ogihara; S Kojima; M Jay
Journal:  Eur J Nucl Med       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.